Sanofi (SNY) and the US buyout firm are set to announce exclusivity as early as Monday, they said. State-owned investment firm Bpifrance is set to take a minority interest in the OTC unit as part ...

Sanofi’s shares traded 0.2% lower on Monday morning in Paris. The stock has risen about 2% over the past 12 months. Despite the commitments it faces in France, CD&R has been drawn to the Sanofi ...

Sanofi announced that it has entered into exclusive negotiations with the US private equity firm Clayton, Dubilier & Rice (CD&R) to transfer around 50% controlling stake in Opella.

Sanofi confirmed on Monday plans to sell a controlling stake in its over-the-counter unit to a US investment fund, after employment and investment guarantees relieved political controversy. The ...

For its “Allegra Airways” campaign, the allergy medication brand used real-time pollen and air pollution data to find pockets ...

The cough and cold relief drugs brand from Procter and Gamble topped the list of Rx and OTC pharma brands by impressions ...

To combat this, allergy medication Allegra created Allegra Airways, a website designed to help find and map real-time routes ...

US-based investment firm takes controlling stake in Opella, while France's government moves to ensure the company remains in ...

(Bloomberg) -- After a year-long takeover battle for the owner of France’s best-selling painkiller, Sanofi’s decision to sell its over-the-counter business to a US buyout firm descended into ...

Sanofi and CD&R enter exclusive talks to sell ... Opella is the third-largest business worldwide in the over-the-counter and vitamins, minerals & supplements market (OTC & VMS), serving over ...

(Bloomberg) — Sanofi entered a fresh round of exclusive negotiations to sell control of its consumer health unit to Clayton Dubilier & Rice after France secured commitments on local employment and ...